Quantum Biopharma Ltd. — Investor Relations & Filings
Filings indexed
337
across all filing types
Latest filing
2026-05-18
Regulatory Filings
Country
US
United States of America
Listing
US
QNTM
Quantum Biopharma Ltd. is a biopharmaceutical company developing a portfolio of assets for neurodegenerative, neuropsychiatric, and inflammatory disorders. The company's lead pharmaceutical candidate is Lucid-MS, a patented, first-in-class neuroprotective compound for Multiple Sclerosis that targets myelin repair and has completed Phase 1 human clinical trials. Alongside its drug development pipeline, Quantum Biopharma is launching unbuzzd™, a functional beverage designed to support mental alertness and detoxification following alcohol consumption. The company's dual strategy focuses on both advanced pharmaceutical research and development and consumer wellness products.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 6-K | 2026-05-18 | English | |
| 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-05-07 | English | |
| 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-04-22 | English | |
| 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-04-02 | English | |
| 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-04-01 | English | |
| 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-03-30 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 46383280 | FORM 6-K | 2026-05-18 | English | ||
| 42821432 | 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-05-07 | English | ||
| 35263952 | 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-04-22 | English | ||
| 33155540 | 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-04-02 | English | ||
| 33134570 | 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-04-01 | English | ||
| 33087644 | 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-03-30 | English | ||
| 33059377 | 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-03-27 | English | ||
| 33052122 | 20-F - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-03-26 | English | ||
| 33048166 | 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-03-26 | English | ||
| 33013173 | 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-03-23 | English | ||
| 31656292 | SCHEDULE 13G/A Filing | 2026-02-03 | English | ||
|
2025
4 filings
| |||||
| 13171354 | FORM 6-K | 2025-12-23 | English | ||
| 13171355 | 6-K | 2025-12-22 | English | ||
| 13171356 | 424B5 | 2025-12-22 | English | ||
| 13171357 | FORM 6-K | 2025-12-22 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BriaCell Therapeutics Corp.
Developing targeted cellular immunotherapies using whole-ce…
|
BCTX | CA | Manufacturing |
|
BridgeBio Oncology Therapeutics, Inc.
Clinical-stage biopharma developing inhibitors for genetica…
|
BBOT | US | Manufacturing |
|
BridgeBio Pharma, Inc.
Develops transformative medicines for genetic diseases and …
|
BBIO | US | Manufacturing |
|
Brightgene Bio-Medical Technology Co., Ltd.
Research-driven developer of complex APIs, high-end generic…
|
688166 | CN | Manufacturing |
|
BRIGHT MINDS BIOSCIENCES INC.
Develops selective serotonin agonists for neurological and …
|
DRUG | US | Manufacturing |
|
BrightPath Biotherapeutics Co., Ltd.
A clinical-stage biopharma company developing cancer immuno…
|
4594 | JP | Manufacturing |
|
Brii Biosciences Limited
Developing first-in-class therapies targeting infectious an…
|
2137 | KY | Manufacturing |
|
BRISTOL MYERS SQUIBB CO
A global biopharmaceutical company that discovers, develops…
|
BMY | US | Manufacturing |
|
BROOKS LABORATORIES LIMITED
Pharmaceutical manufacturer specializing in CRAMS and diver…
|
BROOKS | IN | Manufacturing |
|
BUKWANG PHARMACEUTICAL IND CO.,LTD
An R&D-focused company developing drugs for CNS disorders a…
|
003000 | KR | Manufacturing |
Quantum Biopharma Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34475/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34475 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34475 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34475 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34475}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Quantum Biopharma Ltd. (id: 34475)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.